For the Inventor, By the Inventor

Enter assignee name

Aktiebolaget Astra

Calculating rank

USPTO Granted Patents = 53

Trademarks = 3

Forward Citations = 855

Loading Chart...

Loading Chart...

161 inventors (with patents filed for the assignee):

Leif E Broberg (6 out of 22 patents)

Edib Jakupovic (4 out of 11 patents)

Anders Holmen (4 out of 14 patents)

4. Ralph Lennart Brattsand (3 out of 11 patents)

5. Thomas Hogberg (3 out of 7 patents)

6. Bernard R Boar (3 out of 3 patents)

7. Alan John Cross (3 out of 7 patents)

8. Stinabritt Nilsson (2 out of 10 patents)

9. Peter W Schiller (2 out of 15 patents)

10. Seth-Olov Thorberg (2 out of 32 patents)

11. Peter Edman (2 out of 10 patents)

12. Bror Arne Thalen (2 out of 8 patents)

13. Jan Erik Ulmius (2 out of 2 patents)

14. Jan W Trofast (2 out of 23 patents)

15. Rune V Sandberg (2 out of 4 patents)

Core Competencies:

Glucocorticosteroid Derivatives

Steroid Derivatives

Opioid Receptor Antagonists

Pharmaceutical Composition

Peptide Derivatives

Titanium Implants

Gastric Acid Secretion

Bicyclic Compounds

Organic Salts

Nucleic Acid Probes

Anti-Malarial Agents

Cardiac Glycosides

53 patents: Sort by Forward Citations

1. 6140308 - Colon or ileum-specific glucocorticosteroid derivatives (2000-10-31),

2. 5908833 - Colon or ileum-specific steroid derivatives (1999-06-01),

3. 5800553 - Hip joint prosthesis to be permanently anchored within a femur of a (1998-09-01),

4. 5686428 - Pharmaceutical composition (1997-11-11),

5. 5616483 - Genomic DNA sequences encoding human BSSL/CEL (1997-04-01),

6. 5614514 - Steroid esters (1997-03-25),

7. 5602253 - Peptides derivatives (1997-02-11),

8. 5602099 - .delta. opioid receptor antagonists (1997-02-11),

9. 5599794 - Synergistic combination of a substance with gastric acid secretion (1997-02-04),

10. 5591889 - Method for the synthesis of trisodium phosphonoformate hexahydrate (1997-01-07),

11. 5585378 - Composition containing an oxoindole compound (1996-12-17),

12. 5576296 - Galanin antagonist (1996-11-19),

13. 5562923 - Process for conditioning of water-soluble substances (1996-10-08),

14. 5556964 - Process for the manufacture of budesonide (1996-09-17),

15. 5534644 - Process for the preparation of 4-methyl-5-(2-chloroethyl)-thiazole and (1996-07-09),

Company Overview

Aktiebolaget Astra is a prominent player in the pharmaceutical sector, specializing in the development and manufacturing of innovative drug formulations. The company focuses on a diverse range of therapeutic areas, particularly those involving glucocorticosteroid and steroid derivatives, as well as opioid receptor antagonists. Its research extends to peptide derivatives and advanced pharmaceutical compositions, addressing critical health issues such as gastric acid secretion and pain management. Headquartered in Sweden, Astra is committed to advancing healthcare through cutting-edge technology and scientific research.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

53 Patents

#5 in

#8 in Sweden

#13,339 in the World

Aktiebolaget Astra

Forward Citations = 855

161 inventors:

Leif E Broberg (6 out of 22 patents)

Edib Jakupovic (4 out of 11 patents)

Anders Holmen (4 out of 14 patents)

4. Ralph Lennart Brattsand (3 out of 11 patents)

5. Thomas Hogberg (3 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Aktiebolaget Astra. Retrieved from https://idiyas.com/company/aktiebolaget-astra

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…